Targinact 5 mg - 2,5 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

targinact 5 mg - 2,5 mg tabl. prol.-rel.

mundipharma bv-srl - oxycodone hydrochloride 5 mg - eq. oxycodone 4,5 mg; naloxone hydrochloride dihydrate 2,73 mg - eq. naloxone 2,5 mg - prolonged-release tablet - 5 mg - 2,5 mg - naloxone hydrochloride dihydrate 2.73 mg; oxycodone hydrochloride 5 mg - oxycodone, combinations

Targinact 40 mg - 20 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

targinact 40 mg - 20 mg tabl. prol.-rel.

mundipharma bv-srl - oxycodone hydrochloride 40 mg - eq. oxycodone 36 mg; naloxone hydrochloride dihydrate 21,8 mg - eq. naloxone 20 mg - prolonged-release tablet - 40 mg - 20 mg - naloxone hydrochloride dihydrate 21.8 mg; oxycodone hydrochloride 40 mg - oxycodone, combinations

Targinact 30 mg - 15 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

targinact 30 mg - 15 mg tabl. prol.-rel.

mundipharma bv-srl - oxycodone hydrochloride 30 mg - eq. oxycodone 27 mg; naloxone hydrochloride 15 mg - eq. naloxone 13,5 mg - prolonged-release tablet - 30 mg - 15 mg - oxycodone hydrochloride 30 mg; naloxone hydrochloride 15 mg - oxycodone, combinations

Targinact 2,5 mg - 1,25 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

targinact 2,5 mg - 1,25 mg tabl. prol.-rel.

mundipharma bv-srl - oxycodone hydrochloride 2,5 mg - eq. oxycodone 2,25 mg; naloxone hydrochloride 1,25 mg - eq. naloxone 1,13 mg - prolonged-release tablet - 2,5 mg - 1,25 mg - oxycodone hydrochloride 2.5 mg; naloxone hydrochloride 1.25 mg - oxycodone, combinations

Targinact 15 mg - 7,5 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

targinact 15 mg - 7,5 mg tabl. prol.-rel.

mundipharma bv-srl - oxycodone hydrochloride 15 mg - eq. oxycodone 13,5 mg; naloxone hydrochloride 7,5 mg - eq. naloxone 6,75 mg - prolonged-release tablet - 15 mg - 7,5 mg - oxycodone hydrochloride 15 mg; naloxone hydrochloride 7.5 mg - oxycodone, combinations

Targinact 40mg/20mg modified-release tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

targinact 40mg/20mg modified-release tablets

pilsco ltd - oxycodone hydrochloride; naloxone hydrochloride - modified-release tablet - 40mg ; 20mg

Targinact 5mg/2.5mg modified-release tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

targinact 5mg/2.5mg modified-release tablets

pilsco ltd - oxycodone hydrochloride; naloxone hydrochloride - modified-release tablet - 5mg ; 2.5mg

Targinact 5mg/2.5mg modified-release tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

targinact 5mg/2.5mg modified-release tablets

de pharmaceuticals - oxycodone hydrochloride; naloxone hydrochloride - modified-release tablet - 5mg ; 2.5mg

Targinact 40mg/20mg modified-release tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

targinact 40mg/20mg modified-release tablets

de pharmaceuticals - oxycodone hydrochloride; naloxone hydrochloride - modified-release tablet - 40mg ; 20mg

OXYN-AVENIR 105 mg Israel - English - Ministry of Health

oxyn-avenir 105 mg

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 10 mg; naloxone hydrochloride (as dihydrate) 5 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.